The American Heart Association (AHA) has approved an Innovative Project Award for Dr. Marwan Moussa's project entitled "Paradigm Shift in Primary Aldosteronism Management Utilizing Cell-Free DNA." He will receive a two-year, $200,000 award to support his research.
According to the AHA, the purpose of the Innovative Project Award is "to support highly innovative, high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and/or cerebrovascular research."
The Innovative Project Award promotes unexplored ideas, and "research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities."